Vasoplegia clinical trials at UCSF

1 research study open to eligible people

Vasoplegia is a sudden drop in blood pressure caused by very wide blood vessels. UCSF is studying how drugs help raise blood pressure in people with vasoplegia after surgery. UCSF is testing angiotensin II as a second-line drug during liver transplant and tracking safety and blood pressure.

Showing trials for

  • Angiotensin II in Liver Transplantation

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.

    San Francisco, California

Our lead scientists for Vasoplegia research studies include .

Last updated: